Life ScienceCompany
Bioverativ M&A Summary
Bioverativ has acquired 1 company of its own.
Bioverativ’s largest acquisition to date was in 2017, when it acquired True North Therapeutics for $400M. Bioverativ has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Bioverativ Ownership
Who owns Bioverativ?
Bioverativ is owned by Sanofi SA. It was acquired on January 22, 2018.
Bioverativ Business Overview
Where is Bioverativ headquartered?
Bioverativ is headquartered in Waltham, Massachusetts.
How many employees does Bioverativ have?
Bioverativ has 350 employees.
What sector is Bioverativ in?
Bioverativ is a life science company.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1